Interatrial septal abnormalities and stroke - A meta-analysis of case-control studies

Citation
Jr. Overell et al., Interatrial septal abnormalities and stroke - A meta-analysis of case-control studies, NEUROLOGY, 55(8), 2000, pp. 1172-1179
Citations number
51
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
NEUROLOGY
ISSN journal
00283878 → ACNP
Volume
55
Issue
8
Year of publication
2000
Pages
1172 - 1179
Database
ISI
SICI code
0028-3878(20001024)55:8<1172:ISAAS->2.0.ZU;2-U
Abstract
Objective: To examine the association between patent foramen ovale (PFO) an d atrial septal aneurysm (ASA) and stroke. Method: Data from case-control s tudies that examined the relative frequency of PFO, ASA, or bath, in all pa tients with ischemic stroke, cryptogenic stroke, and known stroke cause as well as control subjects were included. Trials were categorized by age, cli nical comparison, and abnormality. Combined OR were calculated using fixed effect (FE) and random effect (RE) methods. Results: Comparing patients wit h ischemic stroke with control subjects using RE, OR for all ages was 1.83 (95% CI, 1.25 to 2.66) for PFO (15 studies), 2,35 (95% CI, 1.46 to 3.77) fo r ASA (nine studies), and 4.96 (95% CI, 2.37 to 10.39) for PFO plus ASA (fo ur studies). Homogeneous results were found within the group younger than a ge 55: using FE, OR was 3.10 (95% CI, 2.29 to 4.21) for PFO, 6.14 (95% CI, 2,47 to 15.22) for ASA, and 15.59 (95% CI, 2.83 to 85.81) for PFO plus ASA. For patients older than age 55, using FE, OR was 1.27 (95% CI, 0.80 to 2.0 1) for PFO, 3.43 (95% CI, 1.89 to 6.22) for ASA, and 5.09 (95% CI, 1.25 to 20.74) for PFO plus ASA. Comparing cryptogenic stroke with known stroke cau se, heterogeneous results were derived from total group examination using R E: OR was 3.16 (95% CI, 2.30 to 4.35) for PFO (22 studies), 3.65 (95% CI, 1 .34 to 9.97) for ASA (five studies), and 23.26 (95% CI, 5.24 to 103.20) for PFO plus ASA (two studies). In patients younger than. age 55, using FE the OR was 6,00 (95% CI, 3.72 to 9.68) for PFO; only one study examined ASA or PFO plus ASA. In patients aged 55 years or older, three studies produced h eterogeneous results for PFO: using RE, OR was 2.26 (95% CI, 0.96 to 5.31); no data were available on ASA prevalence. Conclusions: PFO and ASA are sig nificantly associated with ischemic stroke in patients younger than 55 year s. Further studies are needed to establish whether an association exists be tween PFO and ischemic stroke in those older than 55.